These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28483308)

  • 1. Travel Times for Screening Mammography: Impact of Geographic Expansion by a Large Academic Health System.
    Rosenkrantz AB; Liang Y; Duszak R; Recht MP
    Acad Radiol; 2017 Sep; 24(9):1125-1131. PubMed ID: 28483308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in Patients' Travel Times among Imaging Examination Types at a Large Academic Health System.
    Rosenkrantz AB; Liang Y; Duszak R; Recht MP
    Acad Radiol; 2017 Aug; 24(8):1008-1012. PubMed ID: 28356203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the closest facility the one actually used? An assessment of travel time estimation based on mammography facilities.
    Alford-Teaster J; Lange JM; Hubbard RA; Lee CI; Haas JS; Shi X; Carlos HA; Henderson L; Hill D; Tosteson AN; Onega T
    Int J Health Geogr; 2016 Feb; 15():8. PubMed ID: 26892310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographic access to mammography facilities and frequency of mammography screening.
    Jewett PI; Gangnon RE; Elkin E; Hampton JM; Jacobs EA; Malecki K; LaGro J; Newcomb PA; Trentham-Dietz A
    Ann Epidemiol; 2018 Feb; 28(2):65-71.e2. PubMed ID: 29439783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Travel Burden to Breast MRI and Utilization: Are Risk and Sociodemographics Related?
    Onega T; Lee CI; Benkeser D; Alford-Teaster J; Haas JS; Tosteson AN; Hill D; Shi X; Henderson LM; Hubbard RA
    J Am Coll Radiol; 2016 Jun; 13(6):611-9. PubMed ID: 27026577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer stage at diagnosis: is travel time important?
    Henry KA; Boscoe FP; Johnson CJ; Goldberg DW; Sherman R; Cockburn M
    J Community Health; 2011 Dec; 36(6):933-42. PubMed ID: 21461957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer stage at diagnosis and geographic access to mammography screening (New Hampshire, 1998-2004).
    Celaya MO; Berke EM; Onega TL; Gui J; Riddle BL; Cherala SS; Rees JR
    Rural Remote Health; 2010; 10(2):1361. PubMed ID: 20438282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographical and seasonal barriers to mammography services and breast cancer stage at diagnosis.
    Onitilo AA; Liang H; Stankowski RV; Engel JM; Broton M; Doi SA; Miskowiak DA
    Rural Remote Health; 2014; 14(3):2738. PubMed ID: 25018129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time and distance barriers to mammography facilities in the Atlanta metropolitan area.
    Peipins LA; Graham S; Young R; Lewis B; Foster S; Flanagan B; Dent A
    J Community Health; 2011 Aug; 36(4):675-83. PubMed ID: 21267639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of County-level Radiologist and Mammography Facility Supply with Screening Mammography Rates in the United States.
    Rosenkrantz AB; Moy L; Fleming MM; Duszak R
    Acad Radiol; 2018 Jul; 25(7):883-888. PubMed ID: 29373212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographic access to breast imaging for US women.
    Onega T; Hubbard R; Hill D; Lee CI; Haas JS; Carlos HA; Alford-Teaster J; Bogart A; DeMartini WB; Kerlikowske K; Virnig BA; Buist DS; Henderson L; Tosteson AN
    J Am Coll Radiol; 2014 Sep; 11(9):874-82. PubMed ID: 24889479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability and accessibility of subsidized mammogram screening program in peninsular Malaysia: A preliminary study using travel impedance approach.
    Mahmud A; Aljunid SM
    PLoS One; 2018; 13(2):e0191764. PubMed ID: 29389972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial equity in facilities providing low- or no-fee screening mammography in Chicago neighborhoods.
    Zenk SN; Tarlov E; Sun J
    J Urban Health; 2006 Mar; 83(2):195-210. PubMed ID: 16736369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic screening: patterns of use and estimated impact on breast carcinoma survival.
    Blanchard K; Colbert JA; Puri D; Weissman J; Moy B; Kopans DB; Kaine EM; Moore RH; Halpern EF; Hughes KS; Tanabe KK; Smith BL; Michaelson JS
    Cancer; 2004 Aug; 101(3):495-507. PubMed ID: 15274062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facility Mammography Volume in Relation to Breast Cancer Screening Outcomes.
    Onega T; Goldman LE; Walker RL; Miglioretti DL; Buist DS; Taplin S; Geller BM; Hill DA; Smith-Bindman R
    J Med Screen; 2016 Mar; 23(1):31-7. PubMed ID: 26265482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography screening: how far is too far?
    Osmun WE; Copeland J; Boisvert L
    Rural Remote Health; 2013; 13(1):2149. PubMed ID: 23406261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammography capacity and appointment wait times: barriers to breast cancer screening.
    Elkin EB; Snow JG; Leoce NM; Atoria CL; Schrag D
    Cancer Causes Control; 2012 Jan; 23(1):45-50. PubMed ID: 22037904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Travel distance to screening facilities and completion of abnormal mammographic follow-up among disadvantaged women.
    Khang L; Adams SA; Steck SE; Zhang J; Xirasagar S; Daguise VG
    Ann Epidemiol; 2017 Jan; 27(1):35-41. PubMed ID: 27729181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammography facilities serving vulnerable women have longer follow-up times.
    Karliner LS; Kaplan C; Livaudais-Toman J; Kerlikowske K
    Health Serv Res; 2019 Feb; 54 Suppl 1(Suppl 1):226-233. PubMed ID: 30394526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic access to radiation therapy facilities and disparities of early-stage breast cancer treatment.
    Lin Y; Wimberly MC; Da Rosa P; Hoover J; Athas WF
    Geospat Health; 2018 May; 13(1):622. PubMed ID: 29772881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.